community download

Presentation: James Gulley

information we require

please check before submitting



Unfortunately the document is not available at this current time, however if you leave your details we'll get it to you as soon as we can.

Please fill in all the information requested. It is very important you enter this information correctly so we can contact you with the document.

Privacy statement »

Manage your email preferences »

Remember my details Information

Information
Remember my details
We place a 'cookie' on your computer so next time you visit us you don't need to fill in all these details

Therapeutic vaccines: advances in understanding of appropriate patient selection and trial design
 
James L. Gulley joined us at the World Vaccine Congress Washington to lead the discussion of appropriate patient selection and trial design in the production of therapeutic vaccines. His conclusions included:
 
• Appropriate endpoints
– Kinetics of clinical response following immune response may be initially subtle or delayed, but potentially long-lasting with growing cumulative benefit
– Immune response is dynamic – broader, better response over time.
– OS (for vaccine alone)
– Urgent need for biomarkers predictive of clinical benefit in immunotherapy studies
• Appropriate patient populations – Earlier is better
 
Why not download the full presentation and find out more about…